NON-SMALL CELL LUNG CANCER STAGE II
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE II explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE II trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug copy tested in lung cancer patients
Disease control OngoingThis study is testing if a new version of the cancer drug pembrolizumab (called SB27) behaves the same way in the body as two existing versions. It involves patients with early-stage lung cancer who have already had surgery and chemotherapy. The main goal is to compare how much d…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE II
Phase: PHASE1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New combo attack on early lung cancer shows promise
Disease control OngoingThis study is testing whether adding an immunotherapy drug called durvalumab to a precise form of radiation therapy (SBRT) works better than radiation alone for early-stage lung cancer. It is for patients with a higher risk of their cancer returning who are not candidates for sur…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE II
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC